Hidden cost of robotic surgery: new study tracks financial strain in cancer patients
NCT ID NCT06955910
First seen May 12, 2026 · Last updated May 12, 2026
Summary
This study looks at the financial burden (called financial toxicity) that people face after having robotic surgery for prostate, bladder, or kidney cancer. Researchers will ask 120 patients to fill out questionnaires about their expenses, travel costs, and support needs. The goal is to understand which patients struggle most financially and what factors contribute to that burden.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Istituto Oncologico Veneto
Padova, Italy/Padova, 35128, Italy
Conditions
Explore the condition pages connected to this study.